SRXH
SRX Global Inc.
NYSE AmericanUSDEQUITY
Consumer Defensive
DELAYED
Last price
1.86
▲ 0.05 (3.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
1.87
Prev close
1.81
Day high
1.94
Day low
1.82
Volume
670.52K
Market cap
$26.62M
P/E (TTM)
—
52W range
0.96 – 42.60
Insider net activity
Net shares
+7.26M
Net buying
Buy transactions
60
7.26M shares
Sell transactions
1
635 shares
Net transactions
+61
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
369.47K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Dec 3, 25 | CONWAY SIMON ALEXANDER MALCOLM Director |
STOCK | 784.13K | $307.35K | Direct |
| Dec 3, 25 | CUNNINGHAM KENT Chief Executive Officer |
STOCK | 655.06K | $1.03M | |
| Aug 25, 25 | WHITE DAVID ALLAN Director |
STOCK | 344.98K | $597.80K | Direct |
| Dec 23, 24 | CONACHER LIONEL F Director |
SELL | 635 | $5.87K | Direct |
| Nov 20, 24 | CONACHER LIONEL F Director |
BUY | 30.46K | $57.61K | Direct |
| Nov 20, 24 | CONACHER LIONEL F Director |
STOCK | 30.46K | $46.05K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CONACHER LIONEL F |
Director | 36.60K | Sale |
CONWAY SIMON ALEXANDER MALCOLM |
Director | 1.04M | Stock Award(Grant) |
CUNNINGHAM KENT |
Chief Executive Officer | — | Stock Award(Grant) |
WHITE DAVID ALLAN |
Director | 731.41K | Stock Award(Grant) |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-3.12%
-1.8%
1M
+3.33%
-0.4%
3M
-75.97%
-79.1%
6M
-75.40%
-86.5%
YTD
-86.40%
-98.7%
1Y
-91.01%
-111.0%
3Y
-99.51%
-173.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$26.62M
Enterprise value$-8.72M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-60.00K
EPS (TTM)$-132.34
Free cash flow—
Total cash$48.19M
Total debt$0
Book value / share$3.29
Shares outstanding14.31M
Float—
Short % of float8.25%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
1.60M
Prior 388.70K
Change vs prior
+310.7%
Shorts adding
% of float
8.25%
Normal
% of shares out
8.18%
Against total outstanding
Days to cover
0.2
Liquid
Float
—
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.56
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin-94.37%
Profit margin0.00%
Return on equity—
Return on assets—
Debt / equity—
Current ratio0.00
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | YoY |
|---|---|---|---|
| Total revenue | $6.53M | $0 | — |
| Operating revenue | $6.53M | $0 | — |
| Cost of revenue | $5.01M | $0 | — |
| Gross profit | $1.53M | $0 | — |
| Selling, general & admin | $12.93M | $0 | — |
| Total operating expense | $12.93M | $0 | — |
| Operating income | -$11.41M | $0 | — |
| Net interest income | -$628.00K | $0 | — |
| Pre-tax income | -$8.64M | $0 | — |
| Tax provision | $0 | $0 | — |
| Net income | -$45.01M | -$43.05M | -4.5% |
| Net income to common | -$45.01M | -$43.05M | -4.5% |
| Basic EPS | -108.38 | -180.63 | +40.0% |
| Diluted EPS | -108.38 | -180.63 | +40.0% |
| EBIT | -$8.01M | $0 | — |
| EBITDA | -$7.98M | $4.39M | -281.9% |
| Basic shares | 415.26K | 238.36K | +74.2% |
| Diluted shares | 415.26K | 238.36K | +74.2% |
| Line item | 2025 | 2024 | YoY |
|---|---|---|---|
| Cash & equivalents | $1.31M | $106.00K | +1,134.9% |
| Cash & short-term investments | $1.31M | $106.00K | +1,134.9% |
| Accounts receivable | $3.94M | $9.28M | -57.5% |
| Inventory | $2.08M | $3.37M | -38.3% |
| Total current assets | $8.13M | $13.64M | -40.4% |
| Property, plant & equipment | $108.00K | $12.52M | -99.1% |
| Goodwill & intangibles | $0 | $7.00M | -100.0% |
| Total assets | $8.40M | $33.76M | -75.1% |
| Total current liabilities | $3.54M | $81.30M | -95.6% |
| Current debt | — | $37.52M | — |
| Long-term debt | $4.45M | $696.00K | +539.7% |
| Total debt | $4.47M | $45.31M | -90.1% |
| Total liabilities | $8.00M | $88.88M | -91.0% |
| Retained earnings | -$22.93M | -$70.03M | +67.3% |
| Shareholder equity | $407.00K | -$55.12M | +100.7% |
| Working capital | $4.58M | -$67.67M | +106.8% |
| Net tangible assets | $407.00K | -$62.12M | +100.7% |
| Shares issued | 415.26K | 238.36K | +74.2% |
| Line item | 2025 | 2024 | YoY |
|---|---|---|---|
| Net income | -$8.64M | -$43.05M | +79.9% |
| Depreciation & amortisation | $31.00K | $4.39M | -99.3% |
| Stock-based compensation | $3.21M | $3.67M | -12.6% |
| Change in working capital | $332.00K | $12.93M | -97.4% |
| Operating cash flow | -$8.14M | -$1.48M | -450.9% |
| Capital expenditure | -$2.08M | — | — |
| Investing cash flow | $5.91M | -$1.09M | +641.7% |
| Share buybacks | -$137.00K | $0 | — |
| Financing cash flow | $12.17M | $932.00K | +1,205.9% |
| Free cash flow | -$10.22M | -$1.48M | -591.4% |
| End cash position | $1.31M | $106.00K | +1,134.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $3.44M | $2.81M | -$34.55M | — | $7.16M | $0 | +22.5% |
| Operating revenue | $3.44M | $2.81M | -$34.55M | — | $7.16M | $0 | +22.5% |
| Cost of revenue | $2.16M | $1.75M | -$25.78M | — | $4.78M | $0 | +23.4% |
| Gross profit | $1.27M | $1.05M | -$8.77M | — | $2.38M | $0 | +21.0% |
| Selling, general & admin | $3.09M | $4.84M | -$26.85M | — | $3.47M | $0 | -36.1% |
| Total operating expense | $3.09M | $4.84M | -$26.85M | — | $3.47M | $0 | -36.1% |
| Operating income | -$1.82M | -$3.79M | $18.08M | — | -$1.09M | $0 | +52.0% |
| Net interest income | -$1.78M | -$1.29M | $2.72M | — | $83.00K | $0 | -38.2% |
| Pre-tax income | -$6.38M | -$8.61M | $21.74M | — | -$962.00K | $0 | +25.9% |
| Tax provision | $2.00K | $4.00K | $630.00K | — | $2.00K | $0 | -50.0% |
| Net income | -$6.38M | -$8.61M | -$15.26M | — | -$964.00K | -$3.98M | +25.9% |
| Net income to common | -$6.38M | -$8.61M | -$15.26M | — | -$964.00K | -$3.98M | +25.9% |
| Basic EPS | -1.20 | -5.23 | — | -44.40 | -4.04 | -16.71 | +77.1% |
| Diluted EPS | -1.20 | -5.23 | — | -44.40 | -4.04 | -16.71 | +77.1% |
| EBIT | -$4.60M | -$7.32M | $21.48M | — | -$1.09M | $0 | +37.2% |
| EBITDA | -$4.60M | -$7.31M | $21.48M | — | -$1.06M | $920.00K | +37.1% |
| Basic shares | 4.98M | 1.65M | — | 340.02K | 238.36K | 238.36K | +202.8% |
| Diluted shares | 4.98M | 1.65M | — | 340.02K | 238.36K | 238.36K | +202.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.54M | $13.06M | $1.31M | — | $1.14M | +57.3% |
| Cash & short-term investments | $26.07M | $13.06M | $1.31M | — | $1.14M | +99.6% |
| Accounts receivable | $3.81M | $3.06M | $3.94M | — | $4.77M | +24.5% |
| Inventory | $2.09M | $1.32M | $2.08M | — | $4.51M | +58.3% |
| Total current assets | $43.15M | $18.84M | $8.13M | — | $14.53M | +129.1% |
| Property, plant & equipment | $76.00K | $73.00K | $108.00K | — | $168.00K | +4.1% |
| Goodwill & intangibles | — | $8.00M | $0 | — | $405.00K | — |
| Total assets | $43.36M | $27.05M | $8.40M | — | $15.29M | +60.3% |
| Total current liabilities | $25.08M | $23.53M | $3.54M | — | $7.32M | +6.6% |
| Current debt | $22.62M | $21.03M | — | — | $1.23M | +7.6% |
| Long-term debt | — | — | $4.45M | — | — | — |
| Total debt | $22.62M | $21.03M | $4.47M | — | $1.28M | +7.6% |
| Total liabilities | $25.08M | $23.53M | $8.00M | — | $7.32M | +6.6% |
| Retained earnings | -$37.92M | -$31.54M | -$22.93M | — | -$322.47M | -20.2% |
| Shareholder equity | $18.29M | $3.52M | $407.00K | — | $7.96M | +418.9% |
| Working capital | $18.07M | -$4.69M | $4.58M | — | $7.21M | +485.1% |
| Net tangible assets | $18.29M | -$4.47M | $407.00K | — | $7.56M | +508.9% |
| Shares issued | 6.93M | 1.65M | 415.26K | 252.68K | 238.36K | +321.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$6.38M | -$8.61M | $21.11M | -$964.00K | -$3.98M | +25.9% |
| Depreciation & amortisation | -$76.00K | $15.00K | -$2.89M | $26.00K | $920.00K | -606.7% |
| Stock-based compensation | $0 | $961.00K | -$1.25M | $280.00K | $424.00K | -100.0% |
| Change in working capital | -$4.60M | $85.00K | $154.00K | $997.00K | $3.98M | -5,516.5% |
| Operating cash flow | -$6.63M | -$2.92M | $7.60M | $384.00K | $1.46M | -126.8% |
| Capital expenditure | — | -$8.46M | — | -$7.00K | -$158.00K | — |
| Investing cash flow | -$7.03M | -$8.46M | -$7.38M | -$1.13M | $2.69M | +16.9% |
| Share buybacks | — | — | $0 | — | — | — |
| Financing cash flow | $21.14M | $23.13M | $9.02M | -$1.19M | -$3.55M | -8.6% |
| Free cash flow | $1.83M | -$11.38M | $7.60M | $377.00K | $1.30M | +116.1% |
| End cash position | $20.54M | $13.06M | $1.31M | $1.14M | $689.00K | +57.3% |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.89%
Held by institutions3.96%
Institutions holding34
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.84
+1.43% from price
SMA 20
1.65
+12.80% from price
SMA 50
3.44
-45.89% from price
SMA 100
5.45
-65.77% from price
SMA 200
9.13
-79.63% from price
EMA 12
1.80
+3.31% from price
EMA 26
2.12
-12.21% from price
EMA 50
3.15
-40.82% from price
RSI (14)
41.9
Neutral
MACD (12,26,9)
-0.32
Hist 0.17
ATR (14)
0.17
9.10% of price
Realised vol 30D
116.4%
Annualised
Bollinger upper
2.05
20, 2σ
Bollinger lower
1.25
20, 2σ
50 / 200 cross
Death
3.44 vs 9.13
Trend bias
Below 200
-79.63%
Risk profile
Beta vs SPY
0.64
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
116.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-96.1%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.17
9.10% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateJul 22, 2026
Next pay dateAug 3, 2026
Last split1:60
Split dateJul 6, 2026
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-19
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K/A · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-07-16
Corporate Changes & Voting Matters
8-K · 2026-07-15
Corporate Changes & Voting Matters
8-K · 2026-07-10
Headlines
SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ...
GuruFocus.com · 9d ago
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
GlobeNewswire · 16d ago
SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics
NewMediaWire · 18d ago
SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub · 18d ago
Top Premarket Gainers
MT Newswires · 19d ago
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
GlobeNewswire · 19d ago
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
GlobeNewswire · 19d ago
SRX Global Acquires Shares in Jersey Mike's IPO
MT Newswires · 23d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.